FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-93 Cr | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-9.84 Cr |
What is the latest Cash Flow from Financing Activities ratio of FDC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-93 Cr |
| Mar2025 | ₹-92 Cr |
| Mar2024 | ₹-202 Cr |
| Mar2023 | ₹-180 Cr |
| Mar2022 | ₹-9.84 Cr |
How is Cash Flow from Financing Activities of FDC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-93 Cr | Negative | |
| Mar2025 | ₹-92 Cr | Negative | |
| Mar2024 | ₹-202 Cr | Negative | |
| Mar2023 | ₹-180 Cr | Negative | |
| Mar2022 | ₹-9.84 Cr | - | |
Compare Cash Flow from Financing Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,718.4 Cr | 6.4% | 0.5% | -22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 6.4% |
0.5% |
-22.3% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses